Innovations in Retinal Imaging: Clinical Takeaways from EnVision Summit 2025 ️

At this year’s EnVision Summit, retinal imaging took centre stage, underscoring how diagnostic technology is reshaping the way we manage complex retinal diseases like geographic atrophy (GA) and age-related macular degeneration (AMD).

Here are some key insights for clinicians:

Multimodal Imaging Is the New Clinical Standard

Optometrists and ophthalmologists alike are embracing OCT, OCTA, fundus autofluorescence, and ultra-widefield imaging as standard tools—not just for diagnosis, but for proactive disease tracking and personalized care.

✅ Early atrophy detection
✅ Perfusion mapping with OCTA
✅ Imaging-guided treatment plans

Biomarkers & AI Are Elevating GA Management

AI-assisted imaging analysis is helping predict GA progression with remarkable accuracy. Imaging biomarkers—such as lesion growth rates and outer retinal changes—are now directly influencing decisions around emerging complement inhibitors and other targeted therapies.

Image-Guided Therapy Is Here to Stay

From trial pipelines to practice, new retinal drugs require precise imaging criteria for initiation and follow-up. This is pushing imaging beyond diagnostics and into the therapeutic realm.

Optometry’s Expanding Role in Co-Managed Retinal Care

With high-resolution imaging now feasible in many primary care settings, optometrists are more integral than ever in:

• Baseline imaging and risk stratification
• Identifying early-stage pathology
• Streamlining referrals to retinal specialists

Bottom Line: Retinal imaging isn’t just about “seeing more”—it’s about seeing sooner and managing smarter. The collaborative future of retinal care will rely on both imaging insights and interdisciplinary teamwork.

Let’s continue raising the standard for early detection and proactive intervention in retinal health.

Are you incorporating multimodal imaging into your practice workflow? What challenges—or opportunities—have you encountered?

#Optometry #Ophthalmology #RetinalImaging #AMD #GeographicAtrophy #EyeCare #EnVision2025 #OptometricTech #AIinHealthcare